Company Overview
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Key Highlights
- Biotechnology · Healthcare
- Led by Jason David Sawyer
- 2 employees
- Based in Edinburgh, FL
Price History
Loading…
Data from Twelve Data. Prices may be delayed.
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 17
G.17 - Industrial Production and Capacity Utilization
9:15 AM ET
Crypto Prices
View more →
Bitcoin (BTC)
68,303 −4.05%
Ethereum (ETH)
1,933 −3.91%
Solana (SOL)
78 −3.81%
Company Facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Edinburgh, FL, GB
- Incorporated
- Oct 11, 2016
- Website
- www.grid-ai.com
Latest SEC Filings
View All Filings →- Current Report (Form 8-K)Oct 30, 2026